The P{GSV1}lolaGS88A8 insertion is still present on the chromosome.
Amino acid replacement: G867D.
G10613768A
G849E | psq-PA; G867E | psq-PB; G867E | psq-PC; G448E | psq-PD; G448E | psq-PE; G448E | psq-PF; G448E | psq-PG; G448E | psq-PH; G442E | psq-PJ; G442E | psq-PK; G851E | psq-PM; G851E | psq-PN; G851E | psq-PO; G448E | psq-PP; G448E | psq-PQ
G867D
The mutation location was inferred from the reported amino acid change, G867D and has been annotated as a G to A change in the second nucleotide of the Gly codon. This would lead to a G867E mutation relative to the reference genome rather than the reported G867D. This may be explained by a polymorphic difference between the mutant strain and the reference genome in the third base of the codon but this is a curator inference.
Flies expressing DlScer\UAS.cDa under the control of Scer\GAL4ey.PH and also carrying lolaGS88A8 and psqrev12 do not produce eye tumours or metastases.
Induced on: the P{GSV1}lolaGS88A8 chromosome. Selected as: a mutation that reverts the tumour phenotype caused by overexpression of both psq and lola from the P{GSV1}lolaGS88A8 insertion under the control of Scer\GAL4ey.PH in the presence of DlScer\UAS.cDa.